electroCore (ECOR)

• Market cap: $64.7M
• 1 day: -3.1%
• 5 days: -8.18%
• 1 month: -37.13%
• 3 months: 12.72%
• 6 months: 16.18%
• Year to date: 57.8%
• 1 year: 46.53%
• 5 years: -49.33%
• 10 years: -97.59%
• Sector: Healthcare
• Industry: Medical Devices

About: electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

Employees: 83